Illumina, Inc. (FRA:ILU)

Market Cap	15.27B -19.5%
Revenue (ttm)	3.69B -0.7%
Net Income	722.50M
EPS	4.63
Shares Out	n/a
PE Ratio	21.14
Forward PE	22.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	44
Open	100.38
Previous Close	101.38
Day's Range	100.38 - 100.38
52-Week Range	62.29 - 132.28
Beta	n/a
RSI	35.00
Earnings Date	Feb 5, 2026

About Illumina

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole...

• Industry: Laboratory Analytical Instruments
• Founded: 1998
• Employees: 8,625
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ILU

Financial Performance

Financial numbers in USD